Apollo Hospitals Enterprise Ltd · APOLLOHOSP
—
—
—
—
—
₹4.3K Cr
₹4.3K Cr
₹4.4K Cr
₹4.8K Cr
₹4.9K Cr
₹4.9K Cr
₹5.1K Cr
₹5.6K Cr
₹5.5K Cr
₹5.6K Cr
₹5.8K Cr
₹6.3K Cr
₹6.5K Cr
₹6.6K Cr
—
20-quarter listed-company comparison
Hospitals Stocks in India
Hospitals: Apollo Hospitals Enterprise Ltd owns the largest revenue base; Narayana Hrudayalaya Ltd has the fastest current growth.
01 · the index people search for
Nifty Hospitals Index — Constituents & Performance
The Hospitals companies below are the listed Indian Hospitals universe this page tracks — the same constituent set people search for as the Nifty Hospitals index. Every figure is equal-weighted across those companies, so one large constituent cannot set the reading. Each number carries its own as-of date.
02 · the sector itself · before any single company
How has Hospitals moved against NIFTY 500?
The line below covers up to 5.2 years and opens on the 5Y view; the buttons cut it shorter. Over the most recent two of them this sector is 48% ahead of NIFTY 500. Earnings across its companies grew 13% on average over the last four reported quarters. It has been ahead of NIFTY 500 on a rolling three-month view for 18 weeks running.
LEADER · ahead 18w✓Price and the fundamentals both up10 of 19 companies ahead of NIFTY 500 by 5% or more over three months1 is 20% or more behind over a year while earnings grew 20% or more
RS ↑18w · 17/19 >200d (+1) · 10/19 lead (−6) · EPS 14/19↑
Hospitals, equal-weighted, based at 200
NIFTY 500, same base, same start
trailing 12-month earnings per share rising
falling
Hospitals, equal-weighted, based at 200
NIFTY 500, same base, same start
trailing 12-month earnings per share rising
falling
Hospitals, equal-weighted, based at 200
NIFTY 500, same base, same start
trailing 12-month earnings per share rising
falling
Both lines start at 200 in the same week, so the distance between them is the whole story: the sector line is an equal-weighted index of its 19 companies. The bars underneath are trailing 12-month earnings per share, one bar per reported quarter, each member rebased to 100 at the start and the sector taking the median — so a price line pulling away from flat bars is a re-rating, not earnings. A bar turns red when that figure is lower than the quarter before. Rules are fixed and applied identically everywhere on this site: ahead by 5% or more over three months, or behind by 20% or more over a year while earnings grew 20% or more. Hover any point to read both values and the gap. This is a description of what the numbers did, not advice.
03 · sector relative strength, before individual stocks
Is Hospitals outperforming NIFTY 500?
Hospitals has outperformed NIFTY 500 by 9% over the last 52 weeks. Over 13 weeks the gap is a lead of 3%. 15 of 19 covered companies currently beat NIFTY on Mansfield relative strength, so leadership inside the sector is selective. Sakar Healthcare Ltd is the strongest against the sector itself at +60%. Readings are as of 2026-08-09.
+3.0%Sector vs NIFTY 500 · 13 weeks
+9.0%Sector vs NIFTY 500 · 52 weeks
15/19Stocks leading NIFTY 500
9/19Stocks leading sector
Sector metric: 21.2 as of 2026-08-09 · NARROWING · rising.
The central tension: the companies with the most scale are not necessarily the companies creating the most change.
Start with scale. Then earnings trajectory. Then business quality. Only after those three agree should price leadership carry much weight.
Bottom line
Hospitals has outperformed NIFTY 500 by 9% over 52 weeks and 3% over 13 weeks. 15 of 19 covered companies beat NIFTY on Mansfield relative strength, while 9 of 19 beat the sector itself. Apollo Hospitals Enterprise Ltd leads with revenue of ₹25,229 crore, based on 19 of 19 comparable companies through Mar 2026.
Companies
19
complete canonical membership
Combined market value
₹5.6 L Cr
Apollo Hospitals Enterprise Ltd
Revenue growing
19/19
positive TTM year-on-year growth
Beating NIFTY 500
15/19
positive Mansfield relative strength
Comparing 5 of 19
04 · research priority, made explicit
Best Hospitals Stocks in India (Aug 2026), Ranked by Data
4-Factor Sector Score
An additive sector-relative research score. The four displayed point contributions always equal the total: Growth & earnings (35), Capital efficiency (25), Valuation (20), and Relative strength (20). Missing or stale evidence is absorbed inside the affected factor, never applied as a hidden adjustment.
Growth & earnings · 35%Capital efficiency · 25%Valuation · 20%Relative strength · 20%
KMC Speciality Hospitals (India) Ltd has the strongest current balance of earnings trajectory, business quality, valuation and price confirmation, with 78.1% evidence confidence.
Indraprastha Medical Corporation Ltd looks inexpensive relative to peers or its own history, but its earnings trajectory has not yet earned the valuation signal.
Global Health Ltd has stronger price confirmation than earnings confirmation; that is a research prompt, not permission to chase.
How this score is built, and what the marks mean
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Top 10 Hospitals Stocks in India
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1KMC Speciality Hospitals (India) Ltd524520 | 79.6/100Favorable setup78% evidence | LEADER | 30.8/35 Revenue 32.5% · PAT 100% · OPM change 6 pp 83% evidence | 20.6/25 ROCE 26% · OPM 31% 76% evidence | 11.4/20 P/E 41.7× · PEG — 50% evidence | 16.8/20 RS sector 23.5% · RS bench 32.2% · 1Y 85.7%12 of 12 weeks ahead 100% evidence |
| Exact sum: 30.8 + 20.6 + 11.4 + 16.8 = 79.6 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence. | ||||||
| 2Artemis Medicare Services LtdARTEMISMED | 70.9/100Favorable setup100% evidence | LEADER | 26.0/35 Revenue 15% · PAT 29.9% · OPM change 4 pp 100% evidence | 13.2/25 ROCE 14.6% · OPM 20% 100% evidence | 14.3/20 P/E 43.2× · PEG 1.09 100% evidence | 17.4/20 RS sector 13.6% · RS bench 22.1% · 1Y 29.1%11 of 12 weeks ahead 100% evidence |
| Exact sum: 26 + 13.2 + 14.3 + 17.4 = 70.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 3Sakar Healthcare LtdSAKAR | 69.9/100Favorable setup87% evidence | LEADER | 32.2/35 Revenue 43.9% · PAT 71.4% · OPM change 5 pp 95% evidence | 11.0/25 ROCE 12.7% · OPM 29% 95% evidence | 6.7/20 P/E 57× · PEG — 50% evidence | 20.0/20 RS sector 60% · RS bench 70.6% · 1Y 169.7%12 of 12 weeks ahead 100% evidence |
| Exact sum: 32.2 + 11 + 6.7 + 20 = 69.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 4Apollo Hospitals Enterprise LtdAPOLLOHOSP | 62.0/100Mixed-positive evidence78% evidence | LEADER | 22.2/35 Revenue 15.8% · PAT 33% · OPM change 1 pp 83% evidence | 14.9/25 ROCE 17.4% · OPM 15% 76% evidence | 12.3/20 P/E 68.7× · PEG — 50% evidence | 12.6/20 RS sector 4.2% · RS bench 12% · 1Y 21.7%8 of 12 weeks ahead 100% evidence |
| Exact sum: 22.2 + 14.9 + 12.3 + 12.6 = 62 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 5Rainbow Childrens Medicare LtdRAINBOW | 59.2/100Mixed-positive evidence100% evidence | LEADER | 17.7/35 Revenue 18.3% · PAT 12.4% · OPM change 0 pp 100% evidence | 17.6/25 ROCE 17.4% · OPM 29% 100% evidence | 7.1/20 P/E 55.2× · PEG 2.97 100% evidence | 16.8/20 RS sector 5.7% · RS bench 13.5% · 1Y 2%12 of 12 weeks ahead 100% evidence |
| Exact sum: 17.7 + 17.6 + 7.1 + 16.8 = 59.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 6Dr Agarwals Eye Hospital LtdDRAGARWQ | 59.1/100Mixed-positive evidence94% evidence | ASLEEP | 20.5/35 Revenue 18.6% · PAT 27.8% · OPM change -2 pp 100% evidence | 17.9/25 ROCE 17.4% · OPM 30% 100% evidence | 12.0/20 P/E 33.5× · PEG 1.41 100% evidence | 8.7/20 RS sector -4% · RS bench 2.7% · 1Y 18.6%3 of 7 weeks ahead 70% evidence |
| Exact sum: 20.5 + 17.9 + 12 + 8.7 = 59.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 7Max Healthcare Institute LtdMAXHEALTH | 57.7/100Mixed-positive evidence90% evidence | TURNING | 25.4/35 Revenue 19.1% · PAT 34% · OPM change 1 pp 88% evidence | 15.9/25 ROCE 14.7% · OPM 28% 100% evidence | 10.8/20 P/E 70.2× · PEG 1.73 100% evidence | 5.6/20 RS sector -7.9% · RS bench -3.1% · 1Y -14.1%2 of 10 weeks ahead 70% evidence |
| Exact sum: 25.4 + 15.9 + 10.8 + 5.6 = 57.7 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -7.9% and the one-year return is -14.1%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 8Global Health LtdMEDANTA | 54.7/100Mixed-positive evidence100% evidence | BREAKING OUT | 11.8/35 Revenue 21.3% · PAT 3.4% · OPM change -2 pp 100% evidence | 14.3/25 ROCE 17.1% · OPM 22% 100% evidence | 11.3/20 P/E 68.4× · PEG 1.11 100% evidence | 17.3/20 RS sector 7.8% · RS bench 15.8% · 1Y 8.8%11 of 12 weeks ahead 100% evidence |
| Exact sum: 11.8 + 14.3 + 11.3 + 17.3 = 54.7 · Decision use: Price leads the evidence: RS versus the benchmark is 15.8%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 9Indraprastha Medical Corporation LtdINDRAMEDCO | 52.7/100Mixed-positive evidence94% evidence | ASLEEP | 12.3/35 Revenue 9.3% · PAT 13.7% · OPM change 0 pp 100% evidence | 18.4/25 ROCE 35.8% · OPM 20% 100% evidence | 17.5/20 P/E 18.6× · PEG 0.92 100% evidence | 4.5/20 RS sector -8.4% · RS bench -14.6% · 1Y -16.1%0 of 10 weeks ahead 70% evidence |
| Exact sum: 12.3 + 18.4 + 17.5 + 4.5 = 52.7 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 10Kovai Medical Center & Hospital LtdKOVAI | 52.1/100Mixed-positive evidence100% evidence | ASLEEP | 20.2/35 Revenue 15.8% · PAT 16.2% · OPM change 1 pp 100% evidence | 18.5/25 ROCE 22.6% · OPM 29% 100% evidence | 9.4/20 P/E 24.9× · PEG 1.7 100% evidence | 4.0/20 RS sector -8.7% · RS bench -1.8% · 1Y -6.6%4 of 12 weeks ahead 100% evidence |
| Exact sum: 20.2 + 18.5 + 9.4 + 4 = 52.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 11GPT Healthcare LtdGPTHEALTH | 51.2/100Mixed-positive evidence74% evidence | TURNING | 14.2/35 Revenue 18% · PAT 0% · OPM change 3 pp 95% evidence | 18.9/25 ROCE 19.9% · OPM 19% 95% evidence | 11.2/20 P/E 27.7× · PEG — 15% evidence | 6.9/20 RS sector -15.8% · RS bench 9.1% · 1Y -11.1%10 of 10 weeks ahead 70% evidence |
| Exact sum: 14.2 + 18.9 + 11.2 + 6.9 = 51.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 12Yatharth Hospital & Trauma Care Services LtdYATHARTH | 51.1/100Mixed-positive evidence78% evidence | FADING | 19.4/35 Revenue 36.1% · PAT 31.5% · OPM change -2 pp 83% evidence | 11.7/25 ROCE 12.4% · OPM 23% 76% evidence | 8.4/20 P/E 47.8× · PEG — 50% evidence | 11.6/20 RS sector 5.7% · RS bench 13.4% · 1Y 36.8%10 of 12 weeks ahead 100% evidence |
| Exact sum: 19.4 + 11.7 + 8.4 + 11.6 = 51.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 13Fortis Healthcare LtdFORTIS | 47.9/100Mixed-negative evidence82% evidence | FADING | 21.3/35 Revenue 17.3% · PAT 31.5% · OPM change -2 pp 95% evidence | 12.6/25 ROCE 13.4% · OPM 21% 76% evidence | 9.4/20 P/E 67.6× · PEG — 50% evidence | 4.6/20 RS sector -6.8% · RS bench 0.2% · 1Y 11.2%7 of 12 weeks ahead 100% evidence |
| Exact sum: 21.3 + 12.6 + 9.4 + 4.6 = 47.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 14Aster DM Quality Care LtdASTERDM | 42.2/100Mixed-negative evidence100% evidence | LEADER | 15.2/35 Revenue 15.7% · PAT 3.7% · OPM change 1 pp 100% evidence | 8.8/25 ROCE 11.4% · OPM 20% 100% evidence | 1.3/20 P/E 210× · PEG 3.07 100% evidence | 16.9/20 RS sector 15.9% · RS bench 24.3% · 1Y 46.1%11 of 12 weeks ahead 100% evidence |
| Exact sum: 15.2 + 8.8 + 1.3 + 16.9 = 42.2 · Decision use: Price leads the evidence: RS versus the benchmark is 24.3%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 15Krishna Institute of Medical Sciences LtdKIMS | 38.0/100Mixed-negative evidence82% evidence | LEADER | 9.7/35 Revenue 30.9% · PAT -52% · OPM change -3 pp 95% evidence | 9.0/25 ROCE 9.5% · OPM 19% 76% evidence | 5.5/20 P/E 163× · PEG — 50% evidence | 13.8/20 RS sector 3.9% · RS bench 11.5% · 1Y 7.2%10 of 12 weeks ahead 100% evidence |
| Exact sum: 9.7 + 9 + 5.5 + 13.8 = 38 · Decision use: Price leads the evidence: RS versus the benchmark is 11.5%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 16Narayana Hrudayalaya LtdNH | 37.8/100Mixed-negative evidence87% evidence | ASLEEP | 12.0/35 Revenue 59.6% · PAT 3.8% · OPM change -5 pp 100% evidence | 11.8/25 ROCE 15.5% · OPM 17% 100% evidence | 6.4/20 P/E 44.7× · PEG 3 65% evidence | 7.6/20 RS sector -4.3% · RS bench 0.3% · 1Y -3.1%5 of 10 weeks ahead 70% evidence |
| Exact sum: 12 + 11.8 + 6.4 + 7.6 = 37.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 17Healthcare Global Enterprises LtdHCG | 32.7/100Adverse evidence69% evidence | TURNING | 10.2/35 Revenue 13.7% · PAT -21.4% · OPM change 0 pp 95% evidence | 6.5/25 ROCE 8.3% · OPM 18% 76% evidence | 8.7/20 P/E 209× · PEG — 15% evidence | 7.3/20 RS sector -8.1% · RS bench 2.9% · 1Y 11.1%8 of 10 weeks ahead 70% evidence |
| Exact sum: 10.2 + 6.5 + 8.7 + 7.3 = 32.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 18Shalby LtdSHALBY | 30.6/100Adverse evidence69% evidence | ASLEEP | 15.4/35 Revenue 4.8% · PAT 100% · OPM change 2 pp 62% evidence | 2.8/25 ROCE 6.5% · OPM 10% 95% evidence | 9.1/20 P/E 46.2× · PEG — 50% evidence | 3.3/20 RS sector -28.4% · RS bench -16% · 1Y -22.2%6 of 10 weeks ahead 70% evidence |
| Exact sum: 15.4 + 2.8 + 9.1 + 3.3 = 30.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 19Jupiter Life Line Hospitals LtdJLHL | 27.5/100Adverse evidence100% evidence | ASLEEP | 7.1/35 Revenue 14.7% · PAT -3.1% · OPM change -3 pp 100% evidence | 10.4/25 ROCE 14.8% · OPM 19% 100% evidence | 6.3/20 P/E 54.9× · PEG 3.44 100% evidence | 3.7/20 RS sector -75.3% · RS bench 12.4% · 1Y -77.7%2 of 12 weeks ahead 100% evidence |
| Exact sum: 7.1 + 10.4 + 6.3 + 3.7 = 27.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
Showing 10 of 19 companies
05 · what price has already done
Market action
Sakar Healthcare Ltd has the strongest one-year price move in Hospitals at +169.7%. It also leads on Mansfield relative strength against NIFTY at +70.6%. 15 of 19 covered companies are above zero on that measure. Every line covers 313 weekly closes through 2026-08-07.
Price and relative strength
Every company, the sector's own index and NIFTY 500 all start level on the left edge of the window, so only the distance between the lines counts — the highest line has risen the most since then, and the chart at the top of this page is drawn the same way. It opens on one year; the buttons beside it stretch that to three or five.
How far ahead of or behind NIFTY 500 each company has been running, measured against its own recent average of that comparison, so the flat line at zero IS NIFTY 500: above it the company is beating the market, below it the market is beating the company. It opens on one year.
The same measure taken against Hospitals itself instead of the whole market, so the flat line at zero is the sector: above it the company is beating its own peers, which is the sharper test of the two. It opens on one year.
06 · compare level, then change
Revenue Scale & Growth Durability
Apollo Hospitals Enterprise Ltd has the highest Revenue among the 19 Hospitals companies compared here, at ₹25,229 crore. Fortis Healthcare Ltd is next at ₹9,128 crore. Narayana Hrudayalaya Ltd has the highest Revenue growth at 59.6%, so level and change sit with different companies. 19 of 19 companies report a comparable reading, the latest through Mar 2026.
What the numbers say: Apollo Hospitals Enterprise Ltd is the scale leader at ₹25,229 crore, 176.4% ahead of Fortis Healthcare Ltd. Narayana Hrudayalaya Ltd's growth is 59.6% from a ₹9,073 crore base, with 20 reported observations in the 20-quarter window. Treat the growth leader as an acceleration candidate, not as equally proven scale.
LeaderApollo Hospitals Enterprise Ltd · ₹25,229 crore
Gap176.4% versus #2 · Fortis Healthcare Ltd
Persistence8/8 recent comparable periods
Coverage19/19 companies · 327 observations
Investor read: Apollo Hospitals Enterprise Ltd is the scale benchmark; Narayana Hrudayalaya Ltd is the acceleration watch. Promote the challenger only if growth persists and converts into margin and returns.
This conclusion weakens if: Apollo Hospitals Enterprise Ltd's growth falls below Narayana Hrudayalaya Ltd's for two consecutive comparable reports while operating margin also compresses.
Revenue is compared on a common reported-currency basis. Growth is year-on-year, so seasonality does not masquerade as progress.
Revenuelargest
Revenue growthfastest growers
Revenue · company comparison
19/19 level · 19/19 change
On every company-comparison chart on this page: solid lines show level, dotted lines show change when “Both” is selected, and a missing report breaks the line rather than being invented.
All-company data · latest reported quarter
In every all-company table on this page, each figure is the company’s latest single reported quarter. The rankings above them use trailing-twelve-month or current-market values, so a company can legitimately show a different number in each.
| Company | Revenue | Revenue growth | Reported |
|---|---|---|---|
| Apollo Hospitals Enterprise Ltd APOLLOHOSP | ₹6.6K Cr | 18% | Mar 2026 |
| Narayana Hrudayalaya Ltd NH | ₹2.7K Cr | 78% | Jun 2026 |
| Fortis Healthcare Ltd FORTIS | ₹2.5K Cr | 17% | Jun 2026 |
| Max Healthcare Institute Ltd MAXHEALTH | ₹2.1K Cr | 12% | Mar 2026 |
| Aster DM Quality Care Ltd ASTERDM | ₹1.3K Cr | 22% | Jun 2026 |
| Global Health Ltd MEDANTA | ₹1.3K Cr | 26% | Jun 2026 |
| Krishna Institute of Medical Sciences Ltd KIMS | ₹1.2K Cr | 35% | Jun 2026 |
| Healthcare Global Enterprises Ltd HCG | ₹695 Cr | 13% | Jun 2026 |
| Rainbow Childrens Medicare Ltd RAINBOW | ₹470 Cr | 33% | Jun 2026 |
| Kovai Medical Center & Hospital Ltd KOVAI | ₹431 Cr | 15% | Jun 2026 |
| Jupiter Life Line Hospitals Ltd JLHL | ₹411 Cr | 16% | Jun 2026 |
| Indraprastha Medical Corporation Ltd INDRAMEDCO | ₹406 Cr | 11% | Jun 2026 |
| Yatharth Hospital & Trauma Care Services Ltd YATHARTH | ₹342 Cr | 47% | Mar 2026 |
| Artemis Medicare Services Ltd ARTEMISMED | ₹287 Cr | 13% | Jun 2026 |
| Shalby Ltd SHALBY⚠ unverified | ₹287 Cr | 8.3% | Mar 2026 |
| Dr Agarwals Eye Hospital Ltd DRAGARWQ | ₹143 Cr | 22% | Jun 2026 |
| GPT Healthcare Ltd GPTHEALTH⚠ unverified | ₹126 Cr | 18% | Jun 2026 |
| KMC Speciality Hospitals (India) Ltd 524520 | ₹82 Cr | 34% | Mar 2026 |
| Sakar Healthcare Ltd SAKAR⚠ unverified | ₹73 Cr | 38% | Jun 2026 |
Full 20-quarter history · every available company
Revenue · reported quarter history
Showing the 12 largest of 19 companies with a series here. The remaining 7 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.
Aster DM Quality Care Ltd · ASTERDM
₹2.5K Cr
₹2.7K Cr
₹2.7K Cr
₹2.7K Cr
₹2.8K Cr
₹3.2K Cr
₹807 Cr
₹841 Cr
₹929 Cr
₹955 Cr
₹974 Cr
₹1.0K Cr
₹1.1K Cr
₹1.1K Cr
₹1.0K Cr
₹1.1K Cr
₹1.2K Cr
₹1.2K Cr
₹1.2K Cr
₹1.3K Cr
Fortis Healthcare Ltd · FORTIS
—
—
—
—
—
₹1.6K Cr
₹1.6K Cr
₹1.7K Cr
₹1.8K Cr
₹1.7K Cr
₹1.8K Cr
₹1.9K Cr
₹2.0K Cr
₹1.9K Cr
₹2.0K Cr
₹2.2K Cr
₹2.3K Cr
₹2.3K Cr
₹2.4K Cr
₹2.5K Cr
Global Health Ltd · MEDANTA
—
₹583 Cr
₹526 Cr
₹619 Cr
₹679 Cr
₹694 Cr
₹707 Cr
₹780 Cr
₹844 Cr
₹836 Cr
₹809 Cr
₹861 Cr
₹957 Cr
₹943 Cr
₹931 Cr
₹1.0K Cr
₹1.1K Cr
₹1.1K Cr
₹1.2K Cr
₹1.3K Cr
Healthcare Global Enterprises Ltd · HCG
—
—
—
—
—
₹425 Cr
₹442 Cr
₹461 Cr
₹487 Cr
₹470 Cr
₹495 Cr
₹526 Cr
₹554 Cr
₹559 Cr
₹585 Cr
₹613 Cr
₹647 Cr
₹633 Cr
₹652 Cr
₹695 Cr
Jupiter Life Line Hospitals Ltd · JLHL
—
—
—
₹203 Cr
₹224 Cr
₹228 Cr
₹242 Cr
₹243 Cr
₹263 Cr
₹273 Cr
₹291 Cr
₹289 Cr
₹335 Cr
₹333 Cr
₹337 Cr
₹353 Cr
₹394 Cr
₹365 Cr
₹388 Cr
₹411 Cr
Kovai Medical Center & Hospital Ltd · KOVAI
₹218 Cr
₹229 Cr
₹220 Cr
₹236 Cr
₹252 Cr
₹264 Cr
₹267 Cr
₹275 Cr
₹303 Cr
₹321 Cr
₹321 Cr
₹315 Cr
₹344 Cr
₹355 Cr
₹357 Cr
₹374 Cr
₹392 Cr
₹407 Cr
₹414 Cr
₹431 Cr
Krishna Institute of Medical Sciences Ltd · KIMS
—
—
—
—
—
₹562 Cr
₹576 Cr
₹606 Cr
₹652 Cr
₹606 Cr
₹634 Cr
₹688 Cr
₹777 Cr
₹772 Cr
₹797 Cr
₹872 Cr
₹961 Cr
₹998 Cr
₹1.1K Cr
₹1.2K Cr
Max Healthcare Institute Ltd · MAXHEALTH
₹1.0K Cr
₹974 Cr
₹944 Cr
₹1.1K Cr
₹1.1K Cr
₹1.1K Cr
₹1.2K Cr
₹1.3K Cr
₹1.4K Cr
₹1.3K Cr
₹1.4K Cr
₹1.5K Cr
₹1.7K Cr
₹1.9K Cr
₹1.9K Cr
₹2.0K Cr
₹2.1K Cr
₹2.1K Cr
₹2.1K Cr
—
Narayana Hrudayalaya Ltd · NH
₹940 Cr
₹960 Cr
₹942 Cr
₹1.0K Cr
₹1.1K Cr
₹1.1K Cr
₹1.2K Cr
₹1.2K Cr
₹1.3K Cr
₹1.2K Cr
₹1.2K Cr
₹1.3K Cr
₹1.4K Cr
₹1.3K Cr
₹1.5K Cr
₹1.5K Cr
₹1.6K Cr
₹2.2K Cr
₹2.6K Cr
₹2.7K Cr
Rainbow Childrens Medicare Ltd · RAINBOW
₹266 Cr
₹249 Cr
₹212 Cr
₹237 Cr
₹313 Cr
₹306 Cr
₹317 Cr
₹287 Cr
₹333 Cr
₹336 Cr
₹341 Cr
₹330 Cr
₹417 Cr
₹398 Cr
₹370 Cr
₹353 Cr
₹445 Cr
₹445 Cr
₹460 Cr
₹470 Cr
Yatharth Hospital & Trauma Care Services Ltd · YATHARTH
—
—
—
—
—
₹138 Cr
₹144 Cr
₹155 Cr
₹171 Cr
₹167 Cr
₹178 Cr
₹212 Cr
₹218 Cr
₹219 Cr
₹232 Cr
₹258 Cr
₹279 Cr
₹320 Cr
₹342 Cr
—
Revenue growth · reported quarter history
Showing the 12 largest of 19 companies with a series here. The remaining 7 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.
Apollo Hospitals Enterprise Ltd · APOLLOHOSP
—
—
—
—
—
—
—
—
—
14%
15%
15%
15%
14%
13%
15%
13%
17%
18%
—
Aster DM Quality Care Ltd · ASTERDM
—
—
—
12%
12%
20%
-70%
-68%
-67%
-70%
21%
19%
17%
10.0%
2.7%
7.6%
10%
13%
18%
22%
Fortis Healthcare Ltd · FORTIS
—
—
—
—
—
—
—
—
—
7.7%
8.7%
12%
12%
15%
12%
17%
17%
17%
18%
17%
Global Health Ltd · MEDANTA
—
—
—
27%
—
19%
34%
26%
24%
20%
14%
10%
13%
13%
15%
20%
15%
19%
24%
26%
Healthcare Global Enterprises Ltd · HCG
—
—
—
—
—
—
—
—
—
11%
12%
14%
14%
19%
18%
17%
17%
13%
11%
13%
Jupiter Life Line Hospitals Ltd · JLHL
—
—
—
—
—
—
—
20%
17%
20%
20%
19%
27%
22%
16%
22%
18%
9.6%
15%
16%
Kovai Medical Center & Hospital Ltd · KOVAI
—
—
—
-1.3%
16%
15%
21%
17%
20%
22%
20%
15%
14%
11%
11%
19%
14%
15%
16%
15%
Krishna Institute of Medical Sciences Ltd · KIMS
—
—
—
—
—
—
—
—
—
7.8%
10%
14%
19%
27%
26%
27%
24%
29%
35%
35%
Max Healthcare Institute Ltd · MAXHEALTH
—
—
—
6.6%
12%
17%
29%
21%
20%
17%
17%
20%
25%
40%
34%
31%
25%
11%
12%
—
Narayana Hrudayalaya Ltd · NH
—
—
—
20%
21%
18%
30%
19%
14%
6.7%
2.0%
5.9%
4.8%
11%
18%
15%
20%
61%
76%
78%
Rainbow Childrens Medicare Ltd · RAINBOW
—
—
—
-3.7%
18%
23%
50%
21%
6.4%
9.8%
7.6%
15%
25%
18%
8.5%
7.0%
6.7%
12%
24%
33%
Yatharth Hospital & Trauma Care Services Ltd · YATHARTH
—
—
—
—
—
—
—
—
—
21%
24%
37%
27%
31%
30%
22%
28%
46%
47%
—
07 · compare level, then change
Operating Economics & Margin Trend
KMC Speciality Hospitals (India) Ltd has the highest OPM among the 19 Hospitals companies compared here, at 31%. Dr Agarwals Eye Hospital Ltd is next at 30%. The same company also holds the highest Margin change, at +6 percentage points. 19 of 19 companies report a comparable reading, the latest through Mar 2026.
What the numbers say: KMC Speciality Hospitals (India) Ltd leads both opm at 31% and margin change at +6 percentage points.
LeaderKMC Speciality Hospitals (India) Ltd · 31%
Gap3.3% versus #2 · Dr Agarwals Eye Hospital Ltd
Persistence4/8 recent comparable periods
Coverage19/19 companies · 366 observations
Investor read: KMC Speciality Hospitals (India) Ltd sets the level benchmark; use the change leader as an inflection watch only after another comparable report confirms it.
This conclusion weakens if: The next two comparable reports reverse the current margin change signal.
Operating margin compares operating profit with revenue. Improvement is measured in percentage points, not percentage growth.
OPMhighest
Margin changefastest expanders
Operating margin · company comparison
19/19 level · 19/19 change
All-company data · latest reported quarter
| Company | OPM | Margin change | Reported |
|---|---|---|---|
| KMC Speciality Hospitals (India) Ltd 524520 | 31% | +6.0 pp | Mar 2026 |
| Dr Agarwals Eye Hospital Ltd DRAGARWQ | 30% | −2.0 pp | Jun 2026 |
| Rainbow Childrens Medicare Ltd RAINBOW | 29% | 0.0 pp | Jun 2026 |
| Kovai Medical Center & Hospital Ltd KOVAI | 29% | +1.0 pp | Jun 2026 |
| Sakar Healthcare Ltd SAKAR⚠ unverified | 29% | +5.0 pp | Jun 2026 |
| Max Healthcare Institute Ltd MAXHEALTH | 28% | +1.0 pp | Mar 2026 |
| Yatharth Hospital & Trauma Care Services Ltd YATHARTH | 23% | −2.0 pp | Mar 2026 |
| Global Health Ltd MEDANTA | 22% | −2.0 pp | Jun 2026 |
| Fortis Healthcare Ltd FORTIS | 21% | −2.0 pp | Jun 2026 |
| Aster DM Quality Care Ltd ASTERDM | 20% | +1.0 pp | Jun 2026 |
| Artemis Medicare Services Ltd ARTEMISMED | 20% | +4.0 pp | Jun 2026 |
| Indraprastha Medical Corporation Ltd INDRAMEDCO | 20% | 0.0 pp | Jun 2026 |
| Krishna Institute of Medical Sciences Ltd KIMS | 19% | −3.0 pp | Jun 2026 |
| Jupiter Life Line Hospitals Ltd JLHL | 19% | −3.0 pp | Jun 2026 |
| GPT Healthcare Ltd GPTHEALTH⚠ unverified | 19% | +3.0 pp | Jun 2026 |
| Healthcare Global Enterprises Ltd HCG | 18% | 0.0 pp | Jun 2026 |
| Narayana Hrudayalaya Ltd NH | 17% | −5.0 pp | Jun 2026 |
| Apollo Hospitals Enterprise Ltd APOLLOHOSP | 15% | +1.0 pp | Mar 2026 |
| Shalby Ltd SHALBY⚠ unverified | 10% | +2.0 pp | Mar 2026 |
Full 20-quarter history · every available company
OPM · reported quarter history
Showing the 12 largest of 19 companies with a series here. The remaining 7 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.
Apollo Hospitals Enterprise Ltd · APOLLOHOSP
17%
16%
13%
13%
13%
11%
11%
12%
13%
13%
13%
13%
15%
14%
14%
15%
15%
15%
15%
—
Aster DM Quality Care Ltd · ASTERDM
14%
15%
17%
11%
11%
14%
15%
14%
15%
16%
16%
16%
20%
18%
18%
19%
20%
17%
19%
20%
Fortis Healthcare Ltd · FORTIS
19%
20%
16%
17%
19%
18%
16%
16%
19%
17%
21%
18%
22%
19%
22%
23%
24%
22%
23%
21%
Global Health Ltd · MEDANTA
—
23%
15%
21%
23%
23%
24%
24%
25%
26%
22%
22%
24%
25%
24%
24%
21%
19%
21%
22%
Healthcare Global Enterprises Ltd · HCG
17%
17%
17%
18%
18%
18%
17%
16%
17%
17%
19%
17%
18%
16%
18%
18%
19%
17%
19%
18%
Jupiter Life Line Hospitals Ltd · JLHL
—
—
—
25%
25%
20%
21%
22%
23%
23%
22%
23%
23%
23%
24%
22%
23%
23%
23%
19%
Kovai Medical Center & Hospital Ltd · KOVAI
29%
28%
25%
26%
27%
27%
25%
25%
28%
30%
29%
27%
28%
29%
28%
28%
27%
28%
27%
29%
Krishna Institute of Medical Sciences Ltd · KIMS
31%
33%
31%
28%
27%
27%
28%
26%
27%
24%
25%
26%
28%
24%
25%
22%
21%
20%
19%
19%
Max Healthcare Institute Ltd · MAXHEALTH
23%
25%
22%
25%
28%
28%
28%
26%
28%
29%
27%
25%
26%
27%
27%
26%
27%
26%
28%
—
Narayana Hrudayalaya Ltd · NH
18%
18%
18%
19%
21%
23%
23%
22%
24%
23%
23%
23%
23%
23%
24%
22%
24%
17%
20%
17%
Rainbow Childrens Medicare Ltd · RAINBOW
34%
36%
23%
35%
35%
35%
31%
31%
35%
35%
31%
28%
35%
34%
31%
29%
33%
33%
31%
29%
Yatharth Hospital & Trauma Care Services Ltd · YATHARTH
30%
—
—
23%
26%
26%
27%
27%
27%
28%
26%
25%
25%
25%
25%
25%
23%
23%
23%
—
Margin change · reported quarter history
Showing the 12 largest of 19 companies with a series here. The remaining 7 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.
Apollo Hospitals Enterprise Ltd · APOLLOHOSP
+6.0 pp
+2.0 pp
−1.3 pp
−1.1 pp
−3.6 pp
−5.1 pp
−2.1 pp
−0.6 pp
+0.0 pp
+2.0 pp
+2.0 pp
+1.0 pp
+2.0 pp
+1.0 pp
+1.0 pp
+2.0 pp
0.0 pp
+1.0 pp
+1.0 pp
—
Aster DM Quality Care Ltd · ASTERDM
+1.6 pp
+0.3 pp
+3.5 pp
−0.9 pp
−2.4 pp
−1.0 pp
−1.9 pp
+3.0 pp
+3.7 pp
+2.0 pp
+1.0 pp
+2.0 pp
+5.0 pp
+2.0 pp
+2.0 pp
+3.0 pp
0.0 pp
−1.0 pp
+1.0 pp
+1.0 pp
Fortis Healthcare Ltd · FORTIS
+7.4 pp
+3.4 pp
+0.3 pp
−2.6 pp
−0.6 pp
−1.6 pp
−0.1 pp
−0.9 pp
+0.2 pp
−1.0 pp
+5.0 pp
+2.0 pp
+3.0 pp
+2.0 pp
+1.0 pp
+5.0 pp
+2.0 pp
+3.0 pp
+1.0 pp
−2.0 pp
Global Health Ltd · MEDANTA
—
—
—
+0.9 pp
—
−0.3 pp
+8.6 pp
+2.5 pp
+1.9 pp
+3.0 pp
−2.0 pp
−2.0 pp
−1.0 pp
−1.0 pp
+2.0 pp
+2.0 pp
−3.0 pp
−6.0 pp
−3.0 pp
−2.0 pp
Healthcare Global Enterprises Ltd · HCG
+4.9 pp
+3.5 pp
+4.1 pp
+1.8 pp
+0.8 pp
+0.5 pp
−0.0 pp
−1.7 pp
−0.8 pp
−0.8 pp
+1.7 pp
+1.0 pp
+1.0 pp
−1.0 pp
−1.0 pp
+1.0 pp
+1.0 pp
+1.0 pp
+1.0 pp
0.0 pp
Jupiter Life Line Hospitals Ltd · JLHL
—
—
—
—
—
—
—
−2.6 pp
−2.0 pp
+3.0 pp
+1.0 pp
+1.0 pp
0.0 pp
0.0 pp
+2.0 pp
−1.0 pp
0.0 pp
0.0 pp
−1.0 pp
−3.0 pp
Kovai Medical Center & Hospital Ltd · KOVAI
−3.8 pp
−1.2 pp
−4.4 pp
−5.3 pp
−2.2 pp
−0.9 pp
+0.3 pp
−1.2 pp
+0.9 pp
+3.0 pp
+4.0 pp
+2.0 pp
0.0 pp
−1.0 pp
−1.0 pp
+1.0 pp
−1.0 pp
−1.0 pp
−1.0 pp
+1.0 pp
Krishna Institute of Medical Sciences Ltd · KIMS
−3.2 pp
+7.2 pp
+2.4 pp
−2.7 pp
−4.3 pp
−6.0 pp
−2.5 pp
−1.7 pp
−0.0 pp
−3.0 pp
−3.0 pp
0.0 pp
+1.0 pp
0.0 pp
0.0 pp
−4.0 pp
−7.0 pp
−4.0 pp
−6.0 pp
−3.0 pp
Max Healthcare Institute Ltd · MAXHEALTH
+10.1 pp
+5.2 pp
+1.3 pp
+0.4 pp
+4.6 pp
+2.7 pp
+5.7 pp
+1.2 pp
−0.1 pp
+1.0 pp
−1.0 pp
−1.0 pp
−2.0 pp
−2.0 pp
0.0 pp
+1.0 pp
+1.0 pp
−1.0 pp
+1.0 pp
—
Narayana Hrudayalaya Ltd · NH
+13.5 pp
+4.4 pp
+1.7 pp
+3.2 pp
+3.6 pp
+5.0 pp
+4.7 pp
+3.4 pp
+2.7 pp
0.0 pp
0.0 pp
+1.0 pp
−1.0 pp
0.0 pp
+1.0 pp
−1.0 pp
+1.0 pp
−6.0 pp
−4.0 pp
−5.0 pp
Rainbow Childrens Medicare Ltd · RAINBOW
—
—
+3.0 pp
+2.9 pp
+1.5 pp
−0.9 pp
+8.4 pp
−3.6 pp
+0.0 pp
0.0 pp
0.0 pp
−3.0 pp
0.0 pp
−1.0 pp
0.0 pp
+1.0 pp
−2.0 pp
−1.0 pp
0.0 pp
0.0 pp
Yatharth Hospital & Trauma Care Services Ltd · YATHARTH
—
—
—
—
−4.0 pp
—
—
+3.9 pp
+0.8 pp
+2.0 pp
−1.0 pp
−2.0 pp
−2.0 pp
−3.0 pp
−1.0 pp
0.0 pp
−2.0 pp
−2.0 pp
−2.0 pp
—
08 · compare level, then change
Profit Scale & Acceleration
Apollo Hospitals Enterprise Ltd has the highest Net profit among the 19 Hospitals companies compared here, at ₹2,002 crore. Max Healthcare Institute Ltd is next at ₹1,442 crore. KMC Speciality Hospitals (India) Ltd has the highest Profit growth at the 100% top of the scoring scale, so level and change sit with different companies.
What the numbers say: Apollo Hospitals Enterprise Ltd leads with ₹2,002 crore of TTM profit, 38.8% above Max Healthcare Institute Ltd. KMC Speciality Hospitals (India) Ltd shows ≥100% on the scoring scale (108.7% uncapped) growth from a ₹48 crore profit base. Compare the size of the base and persistence before ranking acceleration above profit scale.
LeaderApollo Hospitals Enterprise Ltd · ₹2,002 crore
Gap38.8% versus #2 · Max Healthcare Institute Ltd
Persistence8/8 recent comparable periods
Coverage19/19 companies · 327 observations
Investor read: Apollo Hospitals Enterprise Ltd sets the level benchmark; use the change leader as an inflection watch only after another comparable report confirms it.
This conclusion weakens if: The next two comparable reports reverse the current profit growth signal.
Net profit is the residual after operating costs, interest and tax. Growth off a loss or near-zero base is excluded from the fastest-grower rank.
Net profitlargest
Profit growthfastest growers
Net profit · company comparison
19/19 level · 18/19 change
All-company data · latest reported quarter
| Company | Net profit | Profit growth | Reported |
|---|---|---|---|
| Apollo Hospitals Enterprise Ltd APOLLOHOSP | ₹551 Cr | 33% | Mar 2026 |
| Max Healthcare Institute Ltd MAXHEALTH | ₹342 Cr | 7.2% | Mar 2026 |
| Fortis Healthcare Ltd FORTIS | ₹273 Cr | 2.3% | Jun 2026 |
| Narayana Hrudayalaya Ltd NH | ₹207 Cr | 5.1% | Jun 2026 |
| Global Health Ltd MEDANTA | ₹157 Cr | -1.3% | Jun 2026 |
| Kovai Medical Center & Hospital Ltd KOVAI | ₹69 Cr | 21% | Jun 2026 |
| Rainbow Childrens Medicare Ltd RAINBOW | ₹63 Cr | 17% | Jun 2026 |
| Indraprastha Medical Corporation Ltd INDRAMEDCO | ₹56 Cr | 9.8% | Jun 2026 |
| Yatharth Hospital & Trauma Care Services Ltd YATHARTH | ₹45 Cr | 15% | Mar 2026 |
| Jupiter Life Line Hospitals Ltd JLHL | ₹38 Cr | -14% | Jun 2026 |
| Krishna Institute of Medical Sciences Ltd KIMS | ₹37 Cr | -56% | Jun 2026 |
| Artemis Medicare Services Ltd ARTEMISMED | ₹31 Cr | 48% | Jun 2026 |
| Aster DM Quality Care Ltd ASTERDM | ₹29 Cr | -69% | Jun 2026 |
| Dr Agarwals Eye Hospital Ltd DRAGARWQ | ₹23 Cr | 35% | Jun 2026 |
| Shalby Ltd SHALBY⚠ unverified | ₹18 Cr | 250% | Mar 2026 |
| Healthcare Global Enterprises Ltd HCG | ₹16 Cr | 167% | Jun 2026 |
| KMC Speciality Hospitals (India) Ltd 524520 | ₹15 Cr | 200% | Mar 2026 |
| GPT Healthcare Ltd GPTHEALTH⚠ unverified | ₹13 Cr | 63% | Jun 2026 |
| Sakar Healthcare Ltd SAKAR⚠ unverified | ₹10 Cr | 100% | Jun 2026 |
Full 20-quarter history · every available company
Net profit · reported quarter history
Showing the 12 largest of 19 companies with a series here. The remaining 7 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.
Apollo Hospitals Enterprise Ltd · APOLLOHOSP
—
—
—
—
—
₹162 Cr
₹146 Cr
₹173 Cr
₹249 Cr
₹254 Cr
₹258 Cr
₹316 Cr
₹396 Cr
₹379 Cr
₹414 Cr
₹441 Cr
₹494 Cr
₹516 Cr
₹551 Cr
—
Aster DM Quality Care Ltd · ASTERDM
₹128 Cr
₹168 Cr
₹246 Cr
₹80 Cr
₹54 Cr
₹159 Cr
₹183 Cr
₹20 Cr
₹-15 Cr
₹209 Cr
₹-2 Cr
₹5.2K Cr
₹106 Cr
₹64 Cr
₹86 Cr
₹94 Cr
₹121 Cr
₹59 Cr
₹154 Cr
₹29 Cr
Fortis Healthcare Ltd · FORTIS
—
—
—
—
—
₹142 Cr
₹138 Cr
₹124 Cr
₹184 Cr
₹134 Cr
₹203 Cr
₹174 Cr
₹193 Cr
₹254 Cr
₹188 Cr
₹267 Cr
₹329 Cr
₹197 Cr
₹271 Cr
₹273 Cr
Global Health Ltd · MEDANTA
—
₹70 Cr
₹18 Cr
₹59 Cr
₹86 Cr
₹81 Cr
₹101 Cr
₹102 Cr
₹125 Cr
₹124 Cr
₹127 Cr
₹106 Cr
₹131 Cr
₹143 Cr
₹101 Cr
₹159 Cr
₹158 Cr
₹95 Cr
₹142 Cr
₹157 Cr
Healthcare Global Enterprises Ltd · HCG
—
—
—
—
—
₹4 Cr
₹6 Cr
₹4 Cr
₹11 Cr
₹3 Cr
₹23 Cr
₹14 Cr
₹21 Cr
₹8 Cr
₹7 Cr
₹6 Cr
₹21 Cr
₹-8 Cr
₹4 Cr
₹16 Cr
Jupiter Life Line Hospitals Ltd · JLHL
—
—
—
₹30 Cr
₹27 Cr
₹0 Cr
₹16 Cr
₹54 Cr
₹34 Cr
₹44 Cr
₹45 Cr
₹45 Cr
₹52 Cr
₹52 Cr
₹45 Cr
₹44 Cr
₹57 Cr
₹42 Cr
₹50 Cr
₹38 Cr
Kovai Medical Center & Hospital Ltd · KOVAI
₹24 Cr
₹26 Cr
₹19 Cr
₹24 Cr
₹30 Cr
₹31 Cr
₹31 Cr
₹31 Cr
₹43 Cr
₹53 Cr
₹52 Cr
₹46 Cr
₹51 Cr
₹58 Cr
₹55 Cr
₹57 Cr
₹59 Cr
₹65 Cr
₹63 Cr
₹69 Cr
Krishna Institute of Medical Sciences Ltd · KIMS
—
—
—
—
—
₹82 Cr
₹99 Cr
₹87 Cr
₹101 Cr
₹77 Cr
₹72 Cr
₹95 Cr
₹121 Cr
₹92 Cr
₹106 Cr
₹85 Cr
₹72 Cr
₹52 Cr
₹33 Cr
₹37 Cr
Max Healthcare Institute Ltd · MAXHEALTH
₹145 Cr
₹190 Cr
₹124 Cr
₹173 Cr
₹457 Cr
₹222 Cr
₹251 Cr
₹240 Cr
₹277 Cr
₹289 Cr
₹252 Cr
₹236 Cr
₹282 Cr
₹239 Cr
₹319 Cr
₹308 Cr
₹491 Cr
₹301 Cr
₹342 Cr
—
Narayana Hrudayalaya Ltd · NH
₹99 Cr
₹98 Cr
₹69 Cr
₹111 Cr
₹169 Cr
₹154 Cr
₹173 Cr
₹184 Cr
₹227 Cr
₹188 Cr
₹191 Cr
₹202 Cr
₹199 Cr
₹193 Cr
₹197 Cr
₹197 Cr
₹258 Cr
₹127 Cr
₹224 Cr
₹207 Cr
Rainbow Childrens Medicare Ltd · RAINBOW
₹45 Cr
₹45 Cr
₹12 Cr
₹38 Cr
₹61 Cr
₹58 Cr
₹54 Cr
₹42 Cr
₹63 Cr
₹63 Cr
₹51 Cr
₹40 Cr
₹79 Cr
₹69 Cr
₹57 Cr
₹54 Cr
₹76 Cr
₹74 Cr
₹78 Cr
₹63 Cr
Yatharth Hospital & Trauma Care Services Ltd · YATHARTH
—
—
—
—
—
₹21 Cr
₹17 Cr
₹19 Cr
₹28 Cr
₹29 Cr
₹38 Cr
₹30 Cr
₹31 Cr
₹30 Cr
₹39 Cr
₹42 Cr
₹41 Cr
₹43 Cr
₹45 Cr
—
Profit growth · reported quarter history
Showing the 12 largest of 19 companies with a series here. The remaining 7 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.
Apollo Hospitals Enterprise Ltd · APOLLOHOSP
—
—
—
—
—
—
—
—
—
57%
77%
83%
59%
49%
60%
40%
25%
36%
33%
—
Aster DM Quality Care Ltd · ASTERDM
—
—
—
33%
-58%
-5.4%
-26%
-75%
-128%
31%
-101%
—
—
-69%
—
-98%
14%
-7.8%
79%
-69%
Fortis Healthcare Ltd · FORTIS
—
—
—
—
—
—
—
—
—
-5.6%
47%
40%
4.9%
90%
-7.4%
53%
70%
-22%
44%
2.3%
Global Health Ltd · MEDANTA
—
—
—
40%
—
16%
461%
73%
45%
53%
26%
3.9%
4.8%
15%
-20%
50%
21%
-34%
41%
-1.3%
Healthcare Global Enterprises Ltd · HCG
—
—
—
—
—
—
—
—
—
-29%
307%
250%
91%
167%
-70%
-57%
0.0%
-200%
-43%
167%
Jupiter Life Line Hospitals Ltd · JLHL
—
—
—
—
—
—
—
80%
26%
—
181%
-17%
53%
18%
0.0%
-2.2%
9.6%
-19%
11%
-14%
Kovai Medical Center & Hospital Ltd · KOVAI
—
—
—
-31%
25%
19%
63%
29%
43%
71%
68%
48%
19%
9.4%
5.8%
24%
16%
12%
15%
21%
Krishna Institute of Medical Sciences Ltd · KIMS
—
—
—
—
—
—
—
—
—
-6.1%
-27%
9.2%
20%
19%
47%
-11%
-41%
-43%
-69%
-56%
Max Healthcare Institute Ltd · MAXHEALTH
—
—
—
18%
215%
17%
102%
39%
-39%
30%
0.4%
-1.7%
1.8%
-17%
27%
31%
74%
26%
7.2%
—
Narayana Hrudayalaya Ltd · NH
—
—
—
46%
71%
57%
151%
66%
34%
22%
10%
9.8%
-12%
2.7%
3.1%
-2.5%
30%
-34%
14%
5.1%
Rainbow Childrens Medicare Ltd · RAINBOW
—
—
—
5.6%
36%
29%
350%
11%
3.3%
8.6%
-5.6%
-4.8%
25%
9.5%
12%
35%
-3.8%
7.3%
37%
17%
Yatharth Hospital & Trauma Care Services Ltd · YATHARTH
—
—
—
—
—
—
—
—
—
38%
124%
58%
11%
3.5%
2.6%
40%
32%
43%
15%
—
09 · compare level, then change
Return On Capital Employed
Indraprastha Medical Corporation Ltd has the highest ROCE among the 19 Hospitals companies compared here, at 35.8%. KMC Speciality Hospitals (India) Ltd is next at 26%. KMC Speciality Hospitals (India) Ltd has the highest ROCE change at +9 percentage points, so level and change sit with different companies. Its ROCE series carries 15 reported observations across the 20-quarter window.
What the numbers say: Indraprastha Medical Corporation Ltd leads ROCE at 35.8%, 9.8 percentage points above KMC Speciality Hospitals (India) Ltd. KMC Speciality Hospitals (India) Ltd has the strongest latest improvement at +9 percentage points. Read the leader beside the density of its reported history: a sparse high return is a candidate; a repeated high return is evidence of durability.
LeaderIndraprastha Medical Corporation Ltd · 35.8%
Gap37.7% versus #2 · KMC Speciality Hospitals (India) Ltd
Persistence4/8 recent comparable periods
Coverage19/19 companies · 189 observations
Investor read: Indraprastha Medical Corporation Ltd sets the level benchmark; use the change leader as an inflection watch only after another comparable report confirms it.
This conclusion weakens if: The next two comparable reports reverse the current roce change signal.
ROCE asks how much operating return the business earns on the capital employed. Direction matters, but a single exceptional year should not be mistaken for durability.
ROCEhighest
ROCE changefastest improvers
Return on capital · company comparison
19/19 level · 19/19 change
Withheld from this chart: Apollo Hospitals Enterprise Ltd (APOLLOHOSP) — its two data sources disagree by up to 6.3% on reported income across 14 comparable periods, so its derived ratios are withheld; Fortis Healthcare Ltd (FORTIS) — its two data sources disagree by up to 12% on reported income across 14 comparable periods, so its derived ratios are withheld; Krishna Institute of Medical Sciences Ltd (KIMS) — its two data sources disagree by up to 27% on reported income across 14 comparable periods, so its derived ratios are withheld; Healthcare Global Enterprises Ltd (HCG) — its two data sources disagree by up to 95% on reported income across 14 comparable periods, so its derived ratios are withheld; Yatharth Hospital & Trauma Care Services Ltd (YATHARTH) — its two data sources disagree by up to 4.5% on reported income across 14 comparable periods, so its derived ratios are withheld. A figure two sources cannot agree on is not drawn — the gap is a decision, not missing data.
All-company data · latest reported quarter
| Company | ROCE | ROCE change | Reported |
|---|---|---|---|
| Indraprastha Medical Corporation Ltd INDRAMEDCO | 27% | −2.6 pp | Jun 2026 |
| Kovai Medical Center & Hospital Ltd KOVAI | 19% | +0.1 pp | Jun 2026 |
| Rainbow Childrens Medicare Ltd RAINBOW | 15% | −0.6 pp | Jun 2026 |
| Dr Agarwals Eye Hospital Ltd DRAGARWQ | 15% | +0.2 pp | Jun 2026 |
| GPT Healthcare Ltd GPTHEALTH⚠ unverified | 15% | −5.5 pp | Jun 2026 |
| Global Health Ltd MEDANTA | 13% | −3.3 pp | Jun 2026 |
| Sakar Healthcare Ltd SAKAR⚠ unverified | 12% | +3.8 pp | Jun 2026 |
| Max Healthcare Institute Ltd MAXHEALTH | 12% | +0.6 pp | Mar 2026 |
| Jupiter Life Line Hospitals Ltd JLHL | 12% | −2.0 pp | Jun 2026 |
| Artemis Medicare Services Ltd ARTEMISMED | 12% | +2.2 pp | Jun 2026 |
| Narayana Hrudayalaya Ltd NH | 11% | −5.4 pp | Jun 2026 |
| Aster DM Quality Care Ltd ASTERDM | 8.9% | −0.1 pp | Jun 2026 |
| Shalby Ltd SHALBY⚠ unverified | 5.8% | −0.7 pp | Mar 2026 |
Full 20-quarter history · every available company
ROCE · reported quarter history
Showing the 12 largest of 13 companies with a series here. The remaining 1 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.
Artemis Medicare Services Ltd · ARTEMISMED
9.4%
—
8.1%
—
8.6%
—
9.1%
—
10%
13%
12%
15%
9.6%
14%
9.5%
15%
10%
14%
12%
—
Aster DM Quality Care Ltd · ASTERDM
7.6%
—
9.4%
—
8.2%
—
—
—
6.1%
5.4%
4.5%
66%
11%
70%
9.0%
9.9%
8.4%
9.9%
8.9%
—
Dr Agarwals Eye Hospital Ltd · DRAGARWQ
30%
—
14%
—
—
—
16%
—
17%
23%
16%
20%
16%
19%
15%
19%
15%
19%
15%
—
Global Health Ltd · MEDANTA
—
—
8.5%
12%
—
—
14%
—
17%
23%
17%
20%
17%
20%
17%
20%
16%
17%
13%
—
Indraprastha Medical Corporation Ltd · INDRAMEDCO
23%
—
23%
—
28%
—
26%
—
28%
37%
28%
39%
31%
40%
30%
38%
29%
38%
27%
—
Jupiter Life Line Hospitals Ltd · JLHL
—
—
—
—
—
14%
20%
—
17%
21%
18%
23%
18%
23%
14%
19%
14%
18%
12%
—
Kovai Medical Center & Hospital Ltd · KOVAI
15%
—
15%
—
13%
—
15%
—
17%
21%
20%
23%
20%
24%
19%
24%
20%
24%
19%
—
Max Healthcare Institute Ltd · MAXHEALTH
7.7%
—
9.0%
—
9.7%
—
11%
—
12%
15%
12%
15%
12%
14%
11%
14%
12%
14%
12%
—
Narayana Hrudayalaya Ltd · NH
17%
—
21%
—
22%
—
24%
—
24%
30%
26%
27%
14%
24%
16%
21%
17%
20%
11%
—
Rainbow Childrens Medicare Ltd · RAINBOW
17%
19%
19%
—
16%
—
19%
—
18%
22%
16%
19%
16%
20%
16%
20%
15%
19%
15%
—
Sakar Healthcare Ltd · SAKAR⚠ unverified
8.5%
—
9.3%
—
8.0%
—
6.8%
—
6.3%
8.2%
6.5%
7.8%
7.1%
8.1%
8.4%
8.8%
8.4%
11%
12%
—
Shalby Ltd · SHALBY⚠ unverified
9.1%
—
7.7%
—
8.1%
—
8.5%
—
9.9%
13%
11%
12%
8.7%
9.4%
6.5%
6.9%
6.8%
7.2%
5.8%
—
ROCE change · reported quarter history
Showing the 12 largest of 13 companies with a series here. The remaining 1 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.
Artemis Medicare Services Ltd · ARTEMISMED
—
—
—
—
−0.8 pp
—
+1.0 pp
—
+1.6 pp
—
+2.8 pp
—
−0.6 pp
+1.1 pp
−2.4 pp
+0.6 pp
+0.6 pp
−0.4 pp
+2.2 pp
—
Aster DM Quality Care Ltd · ASTERDM
—
—
—
—
+0.6 pp
—
—
—
−2.1 pp
—
—
—
+4.5 pp
+64.9 pp
+4.5 pp
−55.6 pp
−2.2 pp
−60.4 pp
−0.1 pp
—
Dr Agarwals Eye Hospital Ltd · DRAGARWQ
—
—
—
—
—
—
+2.1 pp
—
—
—
−0.8 pp
—
−1.0 pp
−3.6 pp
−0.6 pp
−0.9 pp
−0.9 pp
−0.7 pp
+0.2 pp
—
Global Health Ltd · MEDANTA
—
—
—
—
—
—
+5.2 pp
—
—
—
+3.3 pp
—
−0.2 pp
−2.6 pp
−0.5 pp
+0.2 pp
−1.1 pp
−2.8 pp
−3.3 pp
—
Indraprastha Medical Corporation Ltd · INDRAMEDCO
—
—
—
—
+5.0 pp
—
+3.3 pp
—
−0.3 pp
—
+1.3 pp
—
+2.7 pp
+2.8 pp
+2.1 pp
−1.6 pp
−1.3 pp
−2.2 pp
−2.6 pp
—
Jupiter Life Line Hospitals Ltd · JLHL
—
—
—
—
—
—
—
—
—
+6.2 pp
−1.8 pp
—
+1.0 pp
+2.0 pp
−3.9 pp
−4.3 pp
−3.4 pp
−4.2 pp
−2.0 pp
—
Kovai Medical Center & Hospital Ltd · KOVAI
—
—
—
—
−1.6 pp
—
−0.1 pp
—
+3.7 pp
—
+5.7 pp
—
+3.3 pp
+3.0 pp
−1.3 pp
+0.7 pp
−0.7 pp
+0.1 pp
+0.1 pp
—
Max Healthcare Institute Ltd · MAXHEALTH
—
—
—
—
+2.0 pp
—
+2.3 pp
—
+2.6 pp
—
+0.6 pp
—
−0.7 pp
−1.3 pp
−0.5 pp
−0.7 pp
+0.7 pp
+0.3 pp
+0.6 pp
—
Narayana Hrudayalaya Ltd · NH
—
—
—
—
+4.7 pp
—
+3.7 pp
—
+2.2 pp
—
+1.4 pp
—
−9.8 pp
−5.7 pp
−9.2 pp
−5.9 pp
+2.5 pp
−4.3 pp
−5.4 pp
—
Rainbow Childrens Medicare Ltd · RAINBOW
—
—
—
—
−0.5 pp
—
0.0 pp
—
+1.8 pp
—
−3.1 pp
—
−1.7 pp
−1.3 pp
0.0 pp
+0.3 pp
−0.9 pp
−1.3 pp
−0.6 pp
—
Sakar Healthcare Ltd · SAKAR⚠ unverified
—
—
—
—
−0.5 pp
—
−2.5 pp
—
−1.7 pp
—
−0.3 pp
—
+0.8 pp
−0.1 pp
+1.9 pp
+1.0 pp
+1.3 pp
+2.6 pp
+3.8 pp
—
Shalby Ltd · SHALBY⚠ unverified
—
—
—
—
−1.0 pp
—
+0.8 pp
—
+1.8 pp
—
+2.2 pp
—
−1.2 pp
−3.4 pp
−4.2 pp
−5.5 pp
−1.9 pp
−2.2 pp
−0.7 pp
—
10 · compare level, then change
Valuation Against Growth & Quality
Indraprastha Medical Corporation Ltd has the lowest PEG among the 19 Hospitals companies compared here, at 0.92×. Artemis Medicare Services Ltd is next at 1.09×. The same company also holds the lowest P/E, at 18.6×. 10 of 19 companies report a comparable reading, the latest through Jun 2026. Its PEG series carries 17 reported observations across the 20-quarter window.
What the numbers say: Indraprastha Medical Corporation Ltd has the lowest comparable PEG at 0.92×, 15.6% below Artemis Medicare Services Ltd. Only 10 of 19 companies have earnings and growth steady enough for the ratio to mean anything, so no broad “cheapest stock” conclusion is defensible unless the current multiple, own-history position and growth durability agree.
LeaderIndraprastha Medical Corporation Ltd · 0.92×
Gap15.6% versus #2 · Artemis Medicare Services Ltd
Persistence0/8 recent comparable periods
Coverage10/19 companies · 103 observations
Investor read: Treat valuation as permission to investigate, never as a standalone reason to buy.
This conclusion weakens if: The next two comparable reports reverse the current p/e signal.
PEG is shown only when earnings are positive and three-year EPS growth is between 5% and 60%. It is recomputed consistently as the trailing P/E divided by that growth rate — reported earnings, never an expected-earnings multiple. On Indian companies it is shown only where the two data feeds agreed. Where any of that fails the ratio is left out rather than printed: a P/E divided by a loss, or by growth measured off a tiny base, is a number that looks precise and means nothing.
PEGlowest PEG
P/Elowest P/E
Valuation · company comparison
10/19 level · 19/19 change
All-company data · latest reported quarter
Full 20-quarter history · every available company
PEG · reported quarter history
Artemis Medicare Services Ltd · ARTEMISMED
—
1.2
—
—
—
0.9
0.6
2.6
6.1
3.2
6.0
0.9
1.8
1.2
—
2.1
0.7
5.3
1.1
—
Aster DM Quality Care Ltd · ASTERDM
1.2
0.5
—
—
—
0.6
1.3
—
—
—
—
—
—
11.8
—
—
—
2.0
3.1
—
Dr Agarwals Eye Hospital Ltd · DRAGARWQ
—
—
—
—
—
—
0.2
0.3
1.8
—
0.5
1.3
1.8
5.5
1.5
2.1
2.2
1.7
—
1.4
Global Health Ltd · MEDANTA
—
—
—
—
—
5.2
—
—
1.4
1.3
—
1.7
2.0
3.8
—
—
9.1
—
1.1
—
Indraprastha Medical Corporation Ltd · INDRAMEDCO
—
0.4
—
0.3
0.2
0.3
0.2
0.2
0.3
0.4
0.4
0.4
0.7
2.6
0.7
1.7
1.2
1.3
0.9
—
Jupiter Life Line Hospitals Ltd · JLHL
—
—
—
—
—
—
—
—
12.4
—
—
—
1.4
2.5
—
—
4.6
—
3.4
—
Kovai Medical Center & Hospital Ltd · KOVAI
0.4
0.8
—
—
—
1.0
—
0.7
0.5
—
—
0.5
1.8
3.7
—
1.9
2.0
2.4
1.7
—
Max Healthcare Institute Ltd · MAXHEALTH
—
—
—
3.3
—
2.7
—
—
—
—
9.4
—
—
14.8
—
16.7
6.6
2.8
1.7
—
Narayana Hrudayalaya Ltd · NH
—
—
—
0.8
—
0.6
—
—
—
—
0.6
3.3
1.7
6.6
—
—
—
—
3.0
—
Rainbow Childrens Medicare Ltd · RAINBOW
—
—
—
—
1.6
1.7
—
6.7
1.1
1.7
2.1
—
—
8.9
7.2
6.9
2.8
5.6
5.6
3.0
P/E · reported quarter history
Showing the 12 largest of 19 companies with a series here. The remaining 7 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.
Apollo Hospitals Enterprise Ltd · APOLLOHOSP
118.4
92.1
76.8
67.7
71.3
76.7
81.0
89.5
110.5
117.8
116.0
99.1
100.4
88.1
72.6
72.7
68.6
61.5
59.8
—
Aster DM Quality Care Ltd · ASTERDM
38.7
24.9
22.3
16.9
22.9
23.6
25.0
46.6
67.5
87.6
136.0
139.2
106.8
100.8
90.2
84.9
89.0
85.7
95.2
97.6
Fortis Healthcare Ltd · FORTIS
122.9
81.0
57.9
46.4
48.8
46.3
41.2
44.6
49.1
59.9
59.2
61.1
70.1
74.8
67.1
70.9
76.5
67.7
61.0
68.1
Global Health Ltd · MEDANTA
—
—
—
—
—
60.6
68.1
52.8
51.3
62.9
78.5
73.4
57.5
60.0
65.9
93.2
67.3
60.9
46.8
63.3
Healthcare Global Enterprises Ltd · HCG
—
—
—
—
580.3
484.2
142.5
159.0
169.2
144.2
140.5
122.2
125.4
126.9
142.5
179.9
256.3
280.7
290.6
311.1
Jupiter Life Line Hospitals Ltd · JLHL
—
—
—
—
—
—
—
—
82.1
83.2
48.6
46.0
54.8
55.9
54.6
50.0
51.4
45.8
43.3
47.6
Kovai Medical Center & Hospital Ltd · KOVAI
16.6
17.4
15.7
14.8
17.8
18.7
19.4
21.3
23.1
24.9
25.9
26.1
30.9
32.7
27.5
30.4
33.1
30.4
26.8
31.4
Krishna Institute of Medical Sciences Ltd · KIMS
47.0
54.7
34.5
28.0
38.6
38.9
35.8
43.9
47.0
46.3
48.7
53.8
69.0
72.0
73.5
70.4
78.8
76.3
86.8
129.5
Max Healthcare Institute Ltd · MAXHEALTH
106.4
92.3
59.3
58.9
61.9
45.1
43.8
52.7
47.0
67.3
75.4
86.5
91.8
103.3
100.5
110.3
91.0
74.1
65.0
—
Narayana Hrudayalaya Ltd · NH
58.6
46.0
42.3
38.0
39.1
34.9
31.5
33.5
32.6
33.3
34.0
31.3
30.6
34.2
44.6
58.7
44.8
48.2
40.5
47.0
Rainbow Childrens Medicare Ltd · RAINBOW
—
—
—
50.6
43.1
46.6
43.5
46.3
48.9
56.2
60.0
58.3
65.9
66.0
59.8
64.7
53.7
53.8
45.9
52.1
Yatharth Hospital & Trauma Care Services Ltd · YATHARTH
—
—
—
—
—
—
—
—
37.7
37.6
34.5
29.7
39.0
39.2
28.7
36.9
51.6
43.3
37.0
—
11 · before the conclusion, check the blind spots
What can make this comparison misleading?
This Hospitals comparison names 6 specific ways its own evidence can mislead, all listed below. All 19 companies here report on comparable dates, so no rank carries a stale marker. 3 draw at least one figure from a second feed with too little overlap to cross-check. 5 have second-feed figures withheld because the two sources disagree.
Keep these limits visible
- A high growth rate can be a low-base artefact. The page keeps level and change separate for that reason.
- A high ROCE can be temporary or flattered by a small capital base. Read it beside margin, cash conversion and reinvestment.
- The 4-Factor Sector Score ranks research priority, not portfolio action. Management quality, catalysts and risks need equally fresh evidence before capital is deployed.
- An “all companies” line chart preserves completeness, but rank changes should be checked against reporting dates before drawing a conclusion.
- 3 companies draw at least one figure from a second data feed with too little overlapping history to cross-check against the primary source; they are marked unverified wherever those figures appear.
- 5 companies are missing from the second-feed metrics by decision, not by absence: the two sources disagree, so nothing from the second is drawn. Read those rows as narrower evidence, never as a weaker business.
12 · evidence and freshness
How was this comparison built?
This comparison is built from the reported filings of 19 Hospitals companies, normalized to a common ₹ scale and a shared quarter axis of up to 20 quarters each. Fundamentals run through Jun 2026 and market data through 2026-08-07. A second data feed fills gaps only after identity and scale reconciliation, and missing observations are never interpolated.
FundamentalsThrough Jun 2026 · up to 20 quarters per company
Market dataThrough 2026-08-07 · weekly price and relative-strength history
Derived metricsGrowth, changes and PEG are calculated only when their inputs are comparable.
Score confidenceMissing and stale evidence reduces confidence and pulls the 0–100 research-priority score toward neutral.
Source standing10 cross-checked · 4 unverified · 5 withheld, of 19 graded companies.
How a second data feed is admitted, and what happens when it disagrees
A second feed is read only after its reported income is matched against the primary source on at least three overlapping periods. Where the two agree the figures fill silently. Where there is too little shared history to compare, the figures are still drawn — they are the only evidence there is — and marked ⚠ unverified everywhere they appear. Where the two are known to disagree, nothing from the second feed is drawn and the affected company is named under the chart it is missing from.
13 · questions investors ask, short speakable answers
Hospitals company comparison FAQs
These 24 answers restate the Hospitals comparison above in question form. Every one is computed from the same 19 companies and the same reported filings as the rankings and charts, current through Jun 2026. Price and relative-strength answers run through 2026-08-07. Nothing here is estimated, and none of it is a recommendation.
Is the Hospitals sector outperforming NIFTY 500?
Hospitals has outperformed NIFTY 500 by 9% over 52 weeks and 3% over 13 weeks. 15 of 19 covered companies beat NIFTY on Mansfield relative strength, while 9 of 19 beat the sector itself.
Which Hospitals company is largest by revenue?
Apollo Hospitals Enterprise Ltd leads with revenue of ₹25,229 crore, based on 19 of 19 comparable companies through Mar 2026.
Which Hospitals company is growing fastest?
Narayana Hrudayalaya Ltd has the fastest current revenue growth at 59.6%, across 19 of 19 comparable companies.
Which Hospitals company has the strongest 4-Factor Sector Score?
KMC Speciality Hospitals (India) Ltd ranks first at 79.6/100 with 78.1% evidence confidence. The score prioritizes research; it is not a buy recommendation.
Which Hospitals company has the lowest comparable PEG?
Indraprastha Medical Corporation Ltd has the lowest comparable PEG at 0.92, among 10 of 19 companies whose earnings and growth are steady enough for the ratio to mean anything.
How much history does this Hospitals comparison include?
The page compares up to 20 reported quarters per company for fundamentals, returns and valuation, ending Jun 2026. Missing observations remain blank rather than being estimated.
How is the 4-Factor Sector Score calculated?
The four visible contributions add directly: growth and earnings up to 35 points, capital efficiency up to 25, valuation up to 20, and relative strength up to 20. Missing or stale evidence moves only the affected contribution toward neutral.
Is there a Nifty Hospitals index?
NSE India maintains Nifty indices for several broad sector categories — Nifty Bank, Nifty IT, Nifty Pharma and others — but not for every sub-sector grouping on this site. Whether or not an official Nifty index covers Hospitals, this page builds its own equal-weight basket of 19 listed Hospitals companies — one company, one vote, regardless of market value — so no single large company dominates the reading. Figures are as of Jun 2026.
Which are the best Hospitals stocks in India?
Ranked by this page's four-factor score, KMC Speciality Hospitals (India) Ltd places first among 19 listed Hospitals companies, followed by Artemis Medicare Services Ltd. That is a ranking of published data — earnings, quality, valuation and market behaviour as of Jun 2026 — and not a recommendation; Sector Alpha is not registered with SEBI as an investment adviser.
How many Hospitals stocks are listed in India?
This comparison covers 19 listed Hospitals companies in India, each above the size floor the site applies, with 20 quarters of reported figures per company where the filings exist. The full ranked list is on this page, as of Jun 2026.
Which Hospitals company is the biggest?
Apollo Hospitals Enterprise Ltd is the largest, with trailing-twelve-month revenue of ₹25,229 crore, ahead of Fortis Healthcare Ltd at ₹9,128 crore. That covers 19 of 19 companies with comparable reporting through Mar 2026.
Which Hospitals company has the best profit margins?
KMC Speciality Hospitals (India) Ltd has the highest operating margin at 31%, from 19 of 19 comparable companies. KMC Speciality Hospitals (India) Ltd shows the biggest recent improvement, at +6 percentage points. A high margin matters most when it is holding or rising, not when it is peaking.
Which Hospitals company makes the most profit?
Apollo Hospitals Enterprise Ltd earns the most, at ₹2,002 crore of trailing-twelve-month net profit, from 19 of 19 comparable companies. KMC Speciality Hospitals (India) Ltd has the fastest profit growth at the ≥100% scoring cap, though growth off a small or recovering profit base overstates how much has actually changed.
Which Hospitals company earns the highest return on capital?
Indraprastha Medical Corporation Ltd leads on return on capital employed at 35.8%, across 19 of 19 companies. Read it beside the length of its reported history: a high return that repeats for years is evidence of a durable business, while a single high reading can be a small capital base or one good year.
Which Hospitals stock is the cheapest?
On PEG — where a LOWER number is cheaper — Indraprastha Medical Corporation Ltd screens cheapest at 0.92×. Only 10 of 19 companies have earnings and growth steady enough for the ratio to mean anything, so this is not a sector-wide "cheapest stock" verdict. Cheap on a multiple is a reason to investigate, never a reason to buy on its own.
Is the Hospitals sector beating the market?
Hospitals has outperformed NIFTY 500 by 9% over the last 52 weeks and 3% over 13 weeks, measured on an equal-weight index of its current members. Inside the sector, 15 of 19 covered companies are beating the market on their own. Sector strength does not transfer evenly to every stock in it.
Which Hospitals stock has the strongest price momentum?
Sakar Healthcare Ltd has the strongest relative strength against NIFTY 500. Relative strength answers last, after growth, quality and valuation: price can move well before the fundamentals confirm it, and sometimes without them confirming at all.
Which Hospitals company scores highest for research priority?
KMC Speciality Hospitals (India) Ltd scores 79.6 out of 100 with 78.1% evidence confidence, from 30.8 points on growth and earnings, 20.6 on capital efficiency, 11.4 on valuation and 16.8 on relative strength. This ranks what deserves work next. It is not a buy recommendation, and management quality, catalysts and risk still need separate research.
How many Hospitals companies does this comparison cover, and over what period?
It compares 19 listed companies over up to 20 reported quarters of fundamentals, ending Jun 2026, plus weekly price and relative-strength history. Membership is the full sector list — nothing is dropped for having thin data.
What is the total market cap of the Hospitals sector?
The 19 Hospitals companies on this page carry ₹5,61,672 crore of combined market value. Apollo Hospitals Enterprise Ltd is the largest at ₹1,28,615 crore, about 23% of the sector's total on its own. Market value moves with price, so this reading is dated 2026-08-13.
What is the Hospitals sector's P/E ratio?
The median price-to-earnings ratio across the 19 Hospitals companies on this page is 54.9×, measured on the 19 that report a comparable figure. A sector-level history for this multiple is not held here, so this is a cross-section of today, not a comparison with the sector’s own past. Figures are as of 2026-08-13.
How is the Hospitals sector performing?
15 of the 19 covered Hospitals companies are beating NIFTY 500 on Mansfield relative strength. The sector itself is 9% ahead of NIFTY 500 over 52 weeks on an equal-weight index of its current members. Readings are as of 2026-08-13.
Why are some values on this page blank?
A blank means that company did not report a comparable figure for that period, so nothing is shown. Missing observations are never interpolated, carried forward, or replaced with a similar-looking accounting line, and a company with missing evidence has its research score pulled toward neutral rather than being scored as bad.
Is this investment advice?
No. Every figure here is a deterministic calculation from reported company filings and market data, published for research. It contains no recommendation to buy or sell any security, does not account for your circumstances, and is not a substitute for advice from a licensed adviser.